Stockscreener 앱 받기
11.28
6.21%
0.66
시장 영업 전:
11.15
-0.13
-1.15%
전일 마감가:
$10.62
열려 있는:
$10.62
하루 거래량:
272.77K
Relative Volume:
0.70
시가총액:
$153.65M
수익:
-
순이익/손실:
$-97.17M
주가수익비율:
-1.5111
EPS:
-7.465
순현금흐름:
$-85.97M
1주 성능:
+4.93%
1개월 성능:
-2.76%
6개월 성능:
+56.04%
1년 성능:
+0.71%
1일 변동 폭
$10.12
$11.29
1주일 범위
$9.0501
$11.29
52주 변동 폭
$5.062
$15.10
Immunic Inc Stock (IMUX) Company Profile
명칭
Immunic Inc
전화
(332) 255-9818
주소
1200 AVENUE OF THE AMERICAS, NEW YORK
Compare IMUX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMUX
Immunic Inc
|
11.28 | 153.65M | 0 | -97.17M | -85.97M | -7.465 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-17 | 개시 | Stifel | Buy |
| 2026-04-15 | 다운그레이드 | D. Boral Capital | Buy → Hold |
| 2026-03-24 | 개시 | Guggenheim | Buy |
| 2025-11-07 | 개시 | Roth Capital | Buy |
| 2025-09-29 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-25 | 개시 | William Blair | Outperform |
| 2024-11-25 | 개시 | H.C. Wainwright | Buy |
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
| 2024-08-27 | 개시 | B. Riley Securities | Buy |
| 2022-10-21 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-19 | 재개 | H.C. Wainwright | Buy |
| 2021-04-15 | 개시 | Aegis Capital | Buy |
| 2021-03-24 | 개시 | JMP Securities | Mkt Outperform |
| 2020-10-02 | 개시 | SVB Leerink | Outperform |
| 2020-08-26 | 개시 | Piper Sandler | Overweight |
| 2020-08-07 | 재개 | ROTH Capital | Buy |
| 2020-07-20 | 개시 | BMO Capital Markets | Outperform |
| 2020-06-05 | 개시 | Wedbush | Outperform |
| 2020-05-11 | 개시 | H.C. Wainwright | Buy |
| 2020-03-25 | 개시 | ROTH Capital | Buy |
| 2019-07-11 | 개시 | Chardan Capital Markets | Buy |
모두보기
Immunic Inc 주식(IMUX)의 최신 뉴스
LifeSci Capital Initiates Immunic(IMUX.US) With Buy Rating, Announces Target Price $56 - Moomoo
[EFFECT] IMMUNIC, INC. SEC Filing - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Immunic to Participate in Investor and Medical Conferences in May - Sahm
Who's Buying or Selling Immunic Inc (HAM:10V) Stock Today? - GuruFocus
Immunic Inc (HAM:10V) Valuation - GuruFocus
Immunic Inc (HAM:10V) Dividend - GuruFocus
Immunic Inc (HAM:10V) Stock Price & 30 Year Financial Data - GuruFocus
Immunic Inc (HAM:10V) Competitors 2026 - GuruFocus
Immunic Inc (HAM:10V)Valuation Measures & Financial Statistics - GuruFocus
Immunic Inc Stock Baskets | HAM:10V - GuruFocus
Immunic Inc (HAM:10V) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Immunic Inc Stock Operating Data - GuruFocus
Immunic Inc (HAM:10V) Stock News, Headlines & Updates - GuruFocus
Immunic Inc (HAM:10V) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Immunic Inc (HAM:10V) Stock Earnings Transcripts - GuruFocus
Immunic (NASDAQ: IMUX) registers 45.8M shares after 1-for-10 reverse split - Stock Titan
Q3 2024 Immunic Inc Earnings Call Transcript - GuruFocus
Immunic (IMUX) price target increased by 920.41% to 54.64 - MSN
Immunic Inc (STU:10V) Stock Price & 30 Year Financial Data - GuruFocus
Immunic Inc (STU:10V) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Immunic Inc (STU:10V) Stock Earnings Transcripts - GuruFocus
H.C. Wainwright Maintains Immunic(IMUX.US) With Buy Rating, Cuts Target Price to $22 - Moomoo
IMUX Maintained by HC Wainwright & Co. -- Price Target Raised to $5.00 - GuruFocus
H.C. Wainwright raises Immunic stock price target to $22 on MS drug prospects By Investing.com - Investing.com India
H.C. Wainwright raises Immunic stock price target to $22 on MS drug prospects - Investing.com UK
Immunic (IMUX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Immunic Is Maintained at Buy by HC Wainwright & Co. - Moomoo
Immunic to present MS data, meet investors at May conferences - Proactive financial news
IMUX Forecast, Price Target & Analyst Ratings | IMMUNIC INC (NASDAQ:IMUX) - ChartMill
Immunic, Inc. Common Stock (IMUX) Stock Price Today & Analysis - Gotrade
Debt to equity ratio of Immunic, Inc. – MUN:10V - TradingView
Total liabilities & shareholders' equities of Immunic, Inc. – MUN:10V - TradingView
Current ratio of Immunic, Inc. – MUN:10V - TradingView
Diluted earnings per share (diluted EPS) of Immunic, Inc. – MUN:10V - TradingView
Debt to equity ratio of Immunic, Inc. – LSX:A428WY - TradingView
Pretax income of Immunic, Inc. – MUN:10V - TradingView
Net income of Immunic, Inc. – MUN:10V - TradingView
Debt to equity ratio of Immunic, Inc. – LS:A428WY - TradingView
Total debt per share of Immunic, Inc. – MUN:10V - TradingView
After tax other income/expense of Immunic, Inc. – LS:A428WY - TradingView
Immunic (IMUX) awards CMO 300,000 stock options at $8.80 - Stock Titan
Immunic (IMUX) Chief Medical Officer Michael Panzara files initial Form 3 insider report - Stock Titan
Enterprise value to EBITDA ratio of Immunic, Inc. – TRADEGATE:10V - TradingView
Long term debt to total assets ratio of Immunic, Inc. – TRADEGATE:10V - TradingView
Immunic, Inc. Cash Flow – FWB:10V - TradingView
Asset turnover of Immunic, Inc. – FWB:10V - TradingView
Total liabilities & shareholders' equities of Immunic, Inc. – FWB:10V - TradingView
EBIT per share of Immunic, Inc. – GETTEX:10V - TradingView
Taxes of Immunic, Inc. – GETTEX:10V - TradingView
Current ratio of Immunic, Inc. – GETTEX:10V - TradingView
Immunic Inc (IMUX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Immunic Inc 주식 (IMUX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Tardio Jason | President and COO |
Jun 05 '25 |
Buy |
0.79 |
12,512 |
9,884 |
12,512 |
| Vitt Daniel | CEO and Director |
Jun 04 '25 |
Buy |
0.77 |
15,000 |
11,550 |
29,000 |
| Neermann Joerg | Director |
Jun 04 '25 |
Buy |
0.77 |
70,000 |
53,900 |
170,000 |
| Neermann Joerg | Director |
Jun 05 '25 |
Buy |
0.76 |
30,000 |
22,800 |
200,000 |
| Whaley Glenn | Chief Financial Officer |
Jun 03 '25 |
Buy |
0.71 |
45,000 |
32,076 |
95,510 |
| Rudick Richard Alan | Director |
Jun 03 '25 |
Buy |
0.70 |
143,075 |
100,024 |
230,375 |
0.14%
0.48%
자본화:
|
볼륨(24시간):